imipenem, anhydrous has been researched along with Burns in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.55) | 18.7374 |
1990's | 3 (6.82) | 18.2507 |
2000's | 17 (38.64) | 29.6817 |
2010's | 19 (43.18) | 24.3611 |
2020's | 3 (6.82) | 2.80 |
Authors | Studies |
---|---|
Hatano, K; Ikeda, F; Nakai, T; Takeda, S; Wakai, Y | 1 |
Ali, FA; Bakir, SH; Haji, SH; Hussen, BM | 1 |
Khaledi, A; Khorshidi, A; Mohammadzamani, Z; Moosavi, GA; Piroozmand, A; Shakerimoghaddam, A | 1 |
Akers, KS; Chung, KK; Livezey, JR; Por, ED; Selig, DJ | 1 |
Fu, Y; Huang, G; Peng, Y; Tang, C; Yang, Y | 1 |
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
Azimi, L; Rastegar Lari, A | 1 |
Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
Cui, SY; Fan, YF; Xu, XM; Zhang, C | 1 |
Ben Slama, K; Ben Yahia, H; Chairat, S; Rojo-Bezares, B; Sáenz, Y; Torres, C | 1 |
Chen, DC; Guan, J; Li, WF; Lin, ZF; Liu, SZ; Liu, XF | 1 |
Chen, Z; Liu, P; Liu, S; Pei, D; Xue, X | 1 |
da Silva, JM; Gemperli, R; Gomez, DS; Oliveira, AM; Sanches-Giraud, C; Santos, SR; Silva, CV | 1 |
Decosterd, LA; Eggimann, P; Fournier, A; Marchetti, O; Pagani, JL; Pannatier, A; Que, YA; Revelly, JP; Voirol, P | 1 |
André, C; Arpin, C; Belotti, PT; Coulange-Mayonnove, L; Dubois, V; Laffargue, A; M'Zali, F; Messadi, A; Quentin, C; Thabet, L | 1 |
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Dinghong, M; Fei, G; Guanghua, G; Guohui, L; Jianhua, Z; Nianyun, W; Xili, Y; Yue, L | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Ardebili, A; Azimi, L; Bijari, A; Fallah, F; Lari, AR; Lari, ER | 1 |
Deng, LY; Gong, YL; Huang, GT; Jiang, B; Peng, YZ; Yang, ZC; Yin, SP | 1 |
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A | 1 |
Bahar, MA; Jamali, S; Samadikuchaksaraei, A | 1 |
Bonomo, RA; Cassone, M; Harmos, F; Hoffmann, R; Knappe, D; Kovalszky, I; Ostorhazi, E; Otvos, L; Rozgonyi, F; Szabo, D; Sztodola, A; Wade, JD | 1 |
Boroumand, MA; Habibi, E; Pourgholi, L; Sattarzadeh Tabrizi, M; Sepehriseresht, S; Sotoudeh Anvari, M | 1 |
Han, C; Jin, Y; Zhang, R | 1 |
Qin, X; Xiao, G; Xu, N; Yuan, J; Zheng, J | 1 |
Bozkurt, M; Deveci, M; Ongürü, O; Sengezer, M | 1 |
Bei, CH; Huang, XH; Li, QH; Rong, XZ | 1 |
Bourin, M; Dailly, E; Jolliet, P; Kergueris, MF; Pannier, M | 1 |
Cao, WF; Peng, YZ; Wang, HM; Xiao, GX; Yang, XY | 1 |
Almeida, GD; Costa, SE; Ferreira, AC; Fontana, C; Gobara, S; Levin, AS; Mamizuka, EM; Sauaia, N; Soares, RE; van der Heijden, IM | 1 |
Dai, F; Tan, XD; Wang, JH | 1 |
Akcay, MN; Altoparlak, U; Erol, S; Ertek, M; Ozkurt, Z | 1 |
Arnould, JF; Le Floch, R; Pilorget, A | 1 |
Barnea, Y; Carmeli, Y; Gur, E; Hammer-Munz, O; Kuzmenko, B; Navon-Venezia, S | 1 |
Barnea, Y; Carmeli, Y; Dagan, S; Eren, R; Gat, A; Gur, E; Kuzmenko, B; Navon-Venezia, S; Neville, LF | 1 |
Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM | 1 |
Eslami, G; Khorasani, G; Salehifar, E | 1 |
Härmä, M; Köljalg, S; Lyytikäinen, O; Vuopio-Varkila, J | 1 |
Modakkas, EM; Sanyal, SC | 1 |
Peng, Y; Wang, H; Xiao, G | 1 |
Bombassaro, AM; Boucher, BA; Hickerson, WL; Jaresko, GS; Kuhl, DA | 1 |
Conarro, PA; Culbertson, GR; Mason, AD; McManus, AT; McManus, WF; Pruitt, BA | 1 |
Cumberland, NS; Jones, KP | 1 |
1 review(s) available for imipenem, anhydrous and Burns
Article | Year |
---|---|
Population pharmacokinetics of imipenem in burn patients.
Topics: Burns; Creatinine; Humans; Imipenem; Injections, Intravenous; Metabolic Clearance Rate; Retrospective Studies | 2003 |
2 trial(s) available for imipenem, anhydrous and Burns
Article | Year |
---|---|
[Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone].
Topics: Burns; Cefoperazone; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Tumor Necrosis Factor-alpha | 2004 |
Clinical trial of imipenem/cilastatin in severely burned and infected patients.
Topics: Adult; Aged; Bacterial Infections; Burns; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Pseudomonas aeruginosa; Thienamycins | 1987 |
41 other study(ies) available for imipenem, anhydrous and Burns
Article | Year |
---|---|
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.
Topics: Animals; beta-Lactamases; Burns; Cephalosporins; Drug Resistance, Multiple, Bacterial; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections; Wound Infection | 2007 |
Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Biofilms; Burns; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Homology, Amino Acid | 2021 |
Inhibitory effects of Cinnamaldehyde, Carvacrol, and honey on the expression of exoS and ampC genes in multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infections.
Topics: Acrolein; ADP Ribose Transferases; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Burns; Cymenes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Honey; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Infection | 2020 |
Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Burns; Female; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged; Military Health Services; Monte Carlo Method; Serum Albumin | 2021 |
Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burn Units; Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins; Wound Infection | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Burns; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pumps; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
[Investigation of acquired drug-resistant genes and strains relationship in
Topics: Anti-Bacterial Agents; beta-Lactamases; Burns; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Treatment Outcome | 2018 |
High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Burns; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Integrons; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia; Virulence Factors | 2019 |
Impact of imipenem treatment on colonic mycobiota in rats with double-hit sepsis.
Topics: Animals; Anti-Bacterial Agents; Burns; Candida; Colon; Imipenem; Male; Rats; Rats, Sprague-Dawley; Sepsis; Trichosporon | 2013 |
[Analysis of drug resistance and drug resistance genes of imipenem-resistant Pseudomonas aeruginosa strains isolated from burn wards].
Topics: Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2014 |
Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Female; Glomerular Filtration Rate; Humans; Imipenem; Male; Middle Aged; Probability; Prospective Studies | 2015 |
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Burn Units; Burns; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Computer Systems; Critical Illness; Drug Combinations; Drug Monitoring; Female; Humans; Imipenem; Length of Stay; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Young Adult | 2015 |
Description of an original integron encompassing blaVIM-2, qnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Burn Units; Burns; Conjugation, Genetic; Endemic Diseases; Gene Expression Profiling; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Imipenem; Integrons; Introns; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Transformation, Bacterial; Tunisia | 2015 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
[Analysis of the mechanism of drug resistance of VIM-2-type metallo-β-lactamase-producing Acineto- bacter baumannii isolated from burn patients and its homology].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
Topics: Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriophages; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Liver; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Soft Tissue Infections; Stem Cells | 2016 |
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia | 2008 |
Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-beta-lactamase gene bla(VIM) in a level I Iranian burn hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Burn Units; Burns; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Burns; Colistin; Disease Models, Animal; Female; Humans; Imipenem; Injections, Intramuscular; Mice; Peptides; Plasma; Treatment Outcome; Wound Infection | 2010 |
Detection of vim- and ipm-type metallo-beta-lactamases in Pseudomonas aeruginosa clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Burns; DNA, Bacterial; Female; Genes, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2012 |
[The isolation of Pseudomonas aeruginosa from burn wound and the analysis of its antibiotic resistant spectrum].
Topics: Burns; Cephalosporins; Drug Resistance, Bacterial; Enzyme Induction; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2002 |
[An experimental study of the LPS release from gram-negative bacteria induced by antibiotics (Part two)].
Topics: Animals; Anti-Bacterial Agents; Burns; Ceftazidime; Cell Division; Colony Count, Microbial; Female; Galactosamine; Imipenem; Lipopolysaccharides; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sepsis; Survival Rate; Time Factors | 2002 |
Proliferative "crescentic" glomerulonephritis in a burned patient.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Burns; Glomerulonephritis; Humans; Imipenem; Male; Renal Dialysis; Treatment Outcome | 2003 |
[Clinical evaluation of the postburn retention and the metabolism of Imipenem in the third space].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Burns; Case-Control Studies; Exudates and Transudates; Female; Half-Life; Humans; Imipenem; Male; Young Adult | 2003 |
Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients.
Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Burns; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Intensive Care Units; Male; Pseudomonas aeruginosa | 2004 |
[Effects of early administration of imipenem on subeshcar and plasma TNF-alpha in rabbits with severe burns].
Topics: Animals; Anti-Bacterial Agents; Burns; Endotoxemia; Imipenem; Rabbits; Random Allocation; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
Topics: Adolescent; Anti-Bacterial Agents; Burn Units; Burns; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2005 |
Effect of systematic empiric treatment with imipenem on the bacterial ecology in a burns unit.
Topics: Anti-Bacterial Agents; Bacterial Infections; Burn Units; Burns; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Tobramycin | 2005 |
The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
Topics: Animals; Anti-Bacterial Agents; Burns; Female; Imipenem; Mice; Mice, Inbred C57BL; Pseudomonas Infections; Sepsis; Treatment Outcome; Wound Healing | 2006 |
Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Topics: Animals; Anti-Bacterial Agents; Burns; Disease Models, Animal; Female; Flagellin; Imipenem; Immunoglobulin G; Immunotherapy; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Wound Healing; Wound Infection | 2006 |
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin | 2007 |
Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Child; Ciprofloxacin; Citrobacter freundii; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas Infections; Wound Infection | 2008 |
Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Burns; Cross Infection; Disease Outbreaks; Humans; Imipenem; Infection Control; Microbial Sensitivity Tests; Thienamycins | 1995 |
Imipenem resistance in aerobic gram-negative bacteria.
Topics: beta-Lactam Resistance; Burn Units; Burns; Cross Infection; Gram-Negative Aerobic Bacteria; Humans; Imipenem; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Thienamycins | 1998 |
[Study on the pharmacokinetics of Imipenem cilastatin in burn patients during the acute phase].
Topics: Adult; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Kidney; Male; Metabolic Clearance Rate | 2000 |
Imipenem pharmacokinetics in patients with burns.
Topics: Adult; Burns; Cilastatin; Creatinine; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged | 1990 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |